The Latest Cardiac and Vascular News
CALGARY, Alberta, July 08, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) is pleased to announce today that all patients active in BETonMACE, the Company’s event-based, phase 3 registration trial, recently completed their final, follow-up safety visits, marking another important step towards trial completion. Given the remaining steps […]
DUBLIN, July 08, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced two-year outcomes from the LATERAL clinical trial evaluating the use of its HeartWare™ HVAD™ System in patients who received the system via a less-invasive, thoracotomy implant approach. The HVAD System is a heart pump, called a left ventricular assist device […]
LAKE OSWEGO, Ore., July 8, 2019 /PRNewswire/ — BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope with increased clarity, enabling fast diagnosis and appropriate treatment. Early detection of arrhythmia through ICMs enables physician intervention before adverse outcomes occur. Atrial fibrillation […]
CHICAGO–(BUSINESS WIRE)–Veradigm™, an Allscripts (NASDAQ: MDRX), business unit dedicated to simplifying healthcare with data driven health insights and technologies to help manage costs and improve health outcomes, announced today that it has partnered with the American College of Cardiology (ACC) to power the next generation of real-world research on behalf […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced shipment of its two-millionth AED (Automated External Defibrillator), which was delivered to a customer in Italy. This achievement marks a major milestone in almost 20 years of Philips innovation in cardiac resuscitation aimed at […]
PARIS and NEW YORK, July 03, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, has been selected to enter the European Rising Tech […]
IRVINE, Calif., July 2, 2019 /PRNewswire/ — Inari Medical, Inc. announced today that the company has appointed Thomas M. Tu, M.D. as Chief Medical Officer. Dr. Tu is a pioneer in definitive catheter-based treatment of pulmonary embolism (PE). He was the lead author in the publication of the FLARE trial that resulted in FDA […]
GENT, Belgium–(BUSINESS WIRE)–FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that FEops HEARTguideTM was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the category interventional imaging. This award celebrates promising technologies that will have the […]
Record Revenue Achieved in 1H19 Primarily Due to Increased Demand for Vascepa Guidance for Total 2019 Revenue Increased to a Range of $380 to $420 Million from $350 Million Following Unaudited Second Quarter Results Estimated Between $97 and $101 Million, or Between $170 and $174 Million for the First Half […]
BUCHAREST, Romania, July 2, 2019 /PRNewswire/ — Highlander Partners L.P., a leading middle market private investment firm based in Dallas, Texas, today announced the acquisition of the majority stake in the Ares Group (“Ares”). Founded in 2013 and headquartered in Bucharest, Ares is the leading private provider of interventional cardiology procedures in Romania, with 5 facilities […]
